Emparol Tablet 10 mg contains Empagliflozin, an oral anti-diabetic medication belonging to the SGLT2 (sodium-glucose co-transporter 2) inhibitor class. It is primarily indicated for the management of type 2 diabetes mellitus (T2DM) in adults. Empagliflozin works by inhibiting SGLT2 in the kidneys, reducing glucose reabsorption, and promoting the excretion of excess glucose through urine. This mechanism helps lower blood sugar levels effectively while providing additional benefits such as weight reduction and cardiovascular protection.

Emparol 10 mg is typically prescribed as part of a comprehensive diabetes management plan, which includes dietary control, exercise, and other anti-diabetic medications when necessary. It is suitable for adults who require better glycemic control and long-term management of type 2 diabetes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Emparol Tablet 10 mg is indicated for:

• Type 2 Diabetes Mellitus: To improve glycemic control in adults when diet and exercise alone are insufficient

• Adjunct to other anti-diabetic agents: Can be combined with metformin, sulfonylureas, or insulin under medical supervision

• Cardiovascular risk reduction: In adults with T2DM and established cardiovascular disease, Empagliflozin may reduce the risk of heart failure hospitalization and cardiovascular death

• Weight management: Assists in modest weight reduction through urinary glucose excretion

• Kidney protection: Helps reduce the risk of kidney complications in patients with diabetes

Dosage and Administration

• Adults: One 10 mg tablet once daily, preferably in the morning, with or without food, or as directed by a healthcare professional

• Swallow the tablet whole with water; do not crush or chew

• The dose may be adjusted based on the patient’s glycemic response, kidney function, and tolerance

• Regular monitoring of blood glucose, HbA1c, and renal function is recommended during therapy

• Emparol should be used alongside dietary management and exercise for optimal results

Precautions

• Not recommended for patients with type 1 diabetes, severe kidney impairment, or end-stage renal disease

• Caution in patients with a history of urinary tract infections or genital infections, as SGLT2 inhibitors increase glucose in urine

• Avoid use in patients with severe liver disease unless prescribed by a physician

• Monitor for signs of dehydration, hypotension, or electrolyte imbalance, especially in elderly patients

• Inform your doctor about all medications being taken to prevent interactions, particularly with diuretics, insulin, or other anti-diabetic agents

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Emparol Tablet 10 mg is generally well tolerated. Common side effects may include:

• Increased urination

• Urinary tract infections

• Genital yeast infections

• Thirst or mild dehydration

• Nausea

Rare but serious side effects may include:

• Ketoacidosis (high blood ketones)

• Severe dehydration or low blood pressure

• Hypoglycemia when used with insulin or sulfonylureas

• Kidney impairment or electrolyte imbalance

Patients experiencing serious or persistent side effects should seek immediate medical attention.

Storage

Store in a cool, dry place below 30°C, protected from sunlight and moisture. Keep out of reach of children.

Emparol Tablet 10 mg provides effective glycemic control for type 2 diabetes, along with weight management and cardiovascular protection. Its once-daily dosing and renal mechanism make it a convenient and reliable choice for adults seeking long-term management of diabetes with added heart and kidney benefits.